FDA Drug recall D-1059-2014
Glipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by: Greenstone Ltd., Peapack, NJ --- NDC…
- FDA Drug
- Class III
- terminated
- Published 2014-02-12
On 2014-02-12 the FDA classified a Class III recall of Glipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by: Greenstone Ltd., Peapack, NJ --- NDC… by Greenstone, citing failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1059-2014 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2013-11-04 |
| Published | 2014-02-12 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Greenstone |
| Distribution | US |
Product
Glipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by: Greenstone Ltd., Peapack, NJ --- NDC 59762-5032-2
Reason
Failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval
Identifiers
| code_info | lot V112000, EXP Jun 2016 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1059-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.